| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 660.72B | 563.23B | 611.48B | 601.92B | 512.27B |
| Gross Profit | 161.65B | 127.64B | 116.63B | 113.06B | 98.55B |
| EBITDA | 118.58B | 80.27B | 74.03B | 68.09B | 58.22B |
| Net Income | 78.10B | 57.09B | 45.46B | 41.25B | 35.88B |
Balance Sheet | |||||
| Total Assets | 768.52B | 698.57B | 646.15B | 554.90B | 486.68B |
| Cash, Cash Equivalents and Short-Term Investments | 261.25B | 221.52B | 142.04B | 102.75B | 118.77B |
| Total Debt | 68.14B | 69.22B | 70.62B | 17.67B | 30.54B |
| Total Liabilities | 302.65B | 300.14B | 287.40B | 222.58B | 194.62B |
| Stockholders Equity | 465.86B | 398.09B | 358.41B | 332.02B | 290.77B |
Cash Flow | |||||
| Free Cash Flow | 116.13B | 104.25B | 17.39B | 6.32B | 46.23B |
| Operating Cash Flow | 116.13B | 116.13B | 37.12B | 20.03B | 56.69B |
| Investing Cash Flow | -2.39B | -2.39B | -29.58B | -11.87B | -9.83B |
| Financing Cash Flow | -36.82B | -36.82B | 22.73B | -30.19B | -27.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥281.69B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
78 Outperform | ¥2.55T | 25.53 | 18.63% | 1.30% | 22.53% | 44.96% | |
74 Outperform | ¥581.36B | 20.53 | 5.25% | 2.13% | -7.11% | 68.57% | |
73 Outperform | ¥4.06T | 22.68 | 8.02% | 1.86% | 6.37% | 8.00% | |
69 Neutral | ¥2.94T | 18.60 | 10.09% | 0.97% | 5.35% | 26.51% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥769.25B | 28.52 | 1.88% | 6.16% | 1.98% | -48.28% |